ArticleMedicine2026
Differential associations of distinct anthropometric indices with heart failure in adults with MASLD: A cross-sectional study of NHANES 2017 to 2020.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) is closely linked to cardiovascular morbidity, yet it remains unclear which anthropometric indices most effectively capture the burden of prevalent heart failure (HF) in this population. This cross-sectional study utilized data from the National Health and Nutrition Examination Survey conducted from 2017 to March 2020 (pre-pandemic). MASLD was defined according to the 2023 Delphi consensus as hepatic steatosis plus ≥ 1 cardiometabolic risk factor. HF was defined according to self-reported physician diagnosis of congestive HF. Weighted multivariable logistic regression and restricted cubic splines were used to evaluate the associations of body mass index (BMI), waist circumference (WC), 10 × waist-to-height ratio (10 × WHtR), and body roundness index (BRI) with prevalent HF. Among 2753 participants with MASLD, 96 had HF. In the fully adjusted model, BMI remained independently associated with HF (odds ratio, 1.05; 95% confidence interval, 1.01-1.09). Conversely, the associations for central adiposity indices (WC, 10 × WHtR, and BRI) were attenuated and became nonsignificant after adjusting for metabolic comorbidities. WC tertile categories showed higher odds of HF for the second and third tertiles compared with the lowest tertile, although the overall trend was not statistically significant. Subgroup analyses suggested potential heterogeneity by race/ethnicity and diabetes status, with stronger associations observed among non-Hispanic Asian participants and those without diabetes. Restricted cubic splines analyses indicated linear dose-response relationships for all indices. In adults with MASLD, general obesity (BMI) was independently associated with HF, whereas associations for central adiposity indices were no longer statistically significant after adjustment for metabolic comorbidities. Notably, in subgroup analyses, central obesity markers such as 10 × WHtR and BRI showed stronger associations with HF in non-Hispanic Asians and participants without diabetes, suggesting potential heterogeneity in these associations across clinical subgroups.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.